Search research articles
Contact Us
Filters
Showing results (101-110 of 174) with videos related to
Page
of 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
February 1, 2020
Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Meghan Salcedo, Nikoletta Lendvai, Donna Mastey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
Malin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
Transplantation and Cellular Therapy
|
January 21, 2023
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience
Taxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, et al.
Research Square
|
March 3, 2023
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Blood Cancer Journal
|
January 11, 2023
Extreme body mass index and survival in newly diagnosed multiple myeloma patients
Urvi A Shah, Karissa Whiting, Sean Devlin, et al.
Leukemia & Lymphoma
|
January 9, 2018
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
Nikoletta Lendvai, Ioanna Tsakos, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 31, 2017
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
Meighan Palazzo, Gunjan L Shah, Olivia Copelan, et al.
Blood Cancer Journal
|
February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
Venkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Blood Cancer Journal
|
December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
Venkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Haematologica
|
October 4, 2024
Evaluating serum free light chain ratio as a biomarker in multiple myeloma
Theresia Akhlaghi, Kylee Maclachlan, Neha Korde, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 174) with videos related to
Sort By:
Page
of 18
Clinical Lymphoma, Myeloma & Leukemia
|
February 1, 2020
Phase I Study of Selinexor, Ixazomib, and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Meghan Salcedo, Nikoletta Lendvai, Donna Mastey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 13, 2022
Capture Rate of V(D)J Sequencing for Minimal Residual Disease Detection in Multiple Myeloma
Malin Hultcrantz, Even H Rustad, Venkata Yellapantula, et al.
Transplantation and Cellular Therapy
|
January 21, 2023
Ethical Challenges with Multiple Myeloma BCMA Chimeric Antigen Receptor T Cell Slot Allocation: A Multi-Institution Experience
Taxiarchis Kourelis, Radhika Bansal, Jesus Berdeja, et al.
Research Square
|
March 3, 2023
Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma
Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, et al.
Blood Cancer Journal
|
January 11, 2023
Extreme body mass index and survival in newly diagnosed multiple myeloma patients
Urvi A Shah, Karissa Whiting, Sean Devlin, et al.
Leukemia & Lymphoma
|
January 9, 2018
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
Nikoletta Lendvai, Ioanna Tsakos, Sean M Devlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 31, 2017
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
Meighan Palazzo, Gunjan L Shah, Olivia Copelan, et al.
Blood Cancer Journal
|
February 1, 2020
Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
Venkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Blood Cancer Journal
|
December 13, 2019
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
Venkata Yellapantula, Malin Hultcrantz, Even H Rustad, et al.
Haematologica
|
October 4, 2024
Evaluating serum free light chain ratio as a biomarker in multiple myeloma
Theresia Akhlaghi, Kylee Maclachlan, Neha Korde, et al.
Page
of 18